ClinicalTrials.gg
CompletedNCT06963762Updated Nov 20, 2026

The Effect of Mirror Therapy Applied to Stroke Patients on Motor-Sensory Status and Quality of Life

An interventional study of Conventional rehabilitation will be applied and Mirror therapy will be applied along with conventional rehabilitation in Stroke, Mirror Movement Therapy and Rehabilitation, sponsored by Ataturk University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Ataturk University · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Aug 2024, registered Apr 2025).
Updated Nov 20, 2026Now CompletedFirst site in Turkey (Türkiye)+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 487 studies in Stroke with a site in Turkey — 96 open to participants now, 109 under way, 3 of them phase 3. Stroke · Turkey.

Enrollment
88th of 323
56 · median 40
Started
2024
with 63 others
No phase
294 of 487
58 open now
Registered
327th of 487
by date

Among the 487 studies in Stroke with a site in Turkey, this one is the 88th largest by enrollment of the 323 interventional ones that give a count, is one of 64 that started in 2024, is one of 294 with no phase, and was the 327th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

96 of the 487 studies in Stroke with a site in Turkey are open now. Recruiting first, the newest first:

91 more — sign in →

All 96 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 487 studies in Stroke with a site in Turkey, or all of them as a file.
02

Study summary

Purpose: The research will be conducted to evaluate the effect of Mirror Therapy applied to Stroke Patients on motor-sensory status and quality of life.

Method: The research will be carried out as a randomized controlled experimental study at Bilecik Training and Research Hospital and Bozüyük State Hospital between 01.08.2024-01.05.2025. The population of the research consists of 350 people. Individuals will be distributed to the experimental (30) and control (30) groups by simple randomization method. In collecting research data; The patient introduction form, Brunnstrom Staging and SF-36 Quality of Life Scale will be administered to the patients in both groups by the researcher using face-to-face interview technique (pre-test). Patients in the experimental group will be informed about mirror therapy.

In addition to conventional rehabilitation, patients in the experimental group will receive mirror therapy for 30 minutes, 4 times a week for 4 weeks.

Patients in the control group will only receive conventional rehabilitation for 30 minutes, 4 times a week for 4 weeks. At the end of the 4th week, patients in both groups will be administered Brunnstrom Staging and SF-36 Quality of Life Scale (posttest).

If both groups are discharged before 4 weeks, the planned practices will continue at home.

03

Conditions studied

  • Stroke
  • Mirror Movement Therapy
  • Rehabilitation

Browse trials for

Keywords

  • stroke
  • mirror movement therapy
  • rehabilitation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Being literate,
  2. Being over the age of 18,
  3. Having sufficient communication skills to answer oral and written questions and follow instructions,
  4. Having been diagnosed with a stroke and at least 6 days have passed since it occurred,
  5. Not having severe vision problems,
  6. Not having a vertigo problem,
  7. Not having been diagnosed with epilepsy,
  8. Upper extremity Stage 2 and above in Brunnstrom staging
  9. Lower extremity Stage 2 and above in Brunnstrom staging

Exclusion criteria

Exclusion Criteria:

  1. Being under 18 years of age
  2. Upper extremity Stage 2 and below in Brunnstrom staging
  3. In Brunnstrom staging, Lower extremity Stage 2 and below
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
56 participants (actual)

Study arms

  • Experimental
    conventional rehabilitation group

    Behavioral: Conventional rehabilitation will be applied

  • Experimental
    group receiving mirror therapy along with conventional rehabilitation

    Behavioral: Mirror therapy will be applied along with conventional rehabilitation

Interventions

  • BehavioralConventional rehabilitation will be applied

    Conventional rehabilitation will be applied for 30 minutes, 4 times a week for 4 weeks.

  • BehavioralMirror therapy will be applied along with conventional rehabilitation

    In addition to conventional rehabilitation, patients in the experimental group will receive mirror therapy for 30 minutes, 4 times a week for 4 weeks.

06

What researchers measure

Primary outcomes

  1. Brunnstrom Motor-Sensory Staging

    Brunnstrom staging, which divides the motor recovery process in hemiplegic patients into 6 periods, was used in the upper extremity motor-sensory evaluation of the patients. Brunnstrom staging; Reveals the stages of recovery of patients from hemiplegia after a stroke. It was developed by Swedish physiatrist Signe Brunnström and highlights the synergistic pattern that develops during recovery from stroke.

    Time frame: 1 month

Secondary outcomes

  1. SF-36 Quality of Life Scale

    The SF-36 quality of life scale was used to determine the patients' quality of life. The scale was developed by Ware and Sherbourne in 1992. The validity and reliability of the scale in Turkish was conducted by Koçyiğit. Quality of life scale; It contains 36 statements evaluating 2 main dimensions and 8 sub-dimensions. The scale has Likert type scoring. 35 of the 36 statements in the scale are evaluated considering the last 4 weeks.

    Time frame: 1 month

07

Study locations

1 site
  • Ataturk University
    Erzurum, Turkey (Türkiye)
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2024 to primary completion in May 2025, 9 months.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 9 months is below that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 20, 2026: start May 2025 → Aug 2024, primary completion Jan 2026 → May 2025 and completion Jan 2026 → May 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 10, 2025
First posted
May 9, 2025
StartActual
Aug 1, 2024was May 2025
Primary completionActual
May 30, 2025was Jan 2026
CompletionActual
May 30, 2025was Jan 2026
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Completed
changed Nov 20, 2026
Sites
1 site added — first site in Turkey (Türkiye)
Show site
  • Ataturk University · Erzurum, Turkey (Türkiye)
Nov 20, 2026
Start date
May 2025→Aug 1, 2024 (actual)
Nov 20, 2026
Primary completion
Jan 2026→May 30, 2025 (actual)
Nov 20, 2026
Study completion
Jan 2026→May 30, 2025 (actual)
Nov 20, 2026
Enrollment
60 (estimated)→56 (actual)
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    Not yet recruiting→Completed
    1 site added — first site in Turkey (Türkiye)
    Show site
    • Ataturk University · Erzurum, Turkey (Türkiye)
    Start date May 2025→Aug 1, 2024 (now actual)
    Primary completion Jan 2026→May 30, 2025 (now actual)
    Study completion Jan 2026→May 30, 2025 (now actual)
    Enrollment 60 (estimated)→56 (actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06963762
Lead sponsor
Ataturk University
Responsible party
AHMET ŞİMŞEK (PhD student, Ataturk University) — Principal investigator
First posted
May 9, 2025
Start date
Aug 1, 2024
Primary completion
May 30, 2025
Completion
May 30, 2025
Last update
Nov 20, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion